Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wenjian Min

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
Acta Pharmaceutica Sinica. B|November 8, 2021
Tubeimoside-1 induces TFEB-dependent lysosomal degradation of PD-L1 and promotes antitumor immunity by targeting mTORXiaojia Liu, Mingxiao Yin, Jingwen Dong, et al.
Bioorganic & Medicinal Chemistry Letters|March 17, 2020
Lead discovery, chemical optimization, and biological evaluation studies of novel histone methyltransferase SET7 small-molecule inhibitorsZeng Hou, Wenjian Min, Rukang Zhang, et al.
Kidney International|February 19, 2026
Fibrillin-1 is a novel ligand of the epidermal growth factor receptor promoting mesangial cell activation and glomerulosclerosisMeizhi He, Liuyan Xiao, Zhao Liu, et al.
European Journal of Medicinal Chemistry|December 7, 2021
Discovery of novel and orally bioavailable CDK 4/6 inhibitors with high kinome selectivity, low toxicity and long-acting stability for the treatment of multiple myelomaKai Yuan, Wenbin Kuang, Weijiao Chen, et al.
Journal of Medicinal Chemistry|July 4, 2024
Discovery of Potent and Selective c-Met Degraders for Hepatocellular Carcinoma TreatmentWenjian Min, Huanaoyu Yang, Dawei Wang, et al.
International Journal of Biological Sciences|January 29, 2026
Klotho-derived peptide 1 ameliorates hepatic fibrosis induced by αKlotho deficiency and liver injuryHuishi Tan, Wenshu Huang, Hanying Luo, et al.
Bioorganic & Medicinal Chemistry|February 24, 2020
Computational discovery and biological evaluation of novel inhibitors targeting histone-lysine N-methyltransferase SET7Wenjian Min, Zeng Hou, Fang Zhang, et al.
Journal of Medicinal Chemistry|April 27, 2024
Design, Synthesis, and Biological Evaluation of Novel EGFR PROTACs Targeting C797S MutationYasheng Zhu, Xiuquan Ye, Yuxing Wu, et al.
Journal of Medicinal Chemistry|January 10, 2025
Discovery of Novel Small-Molecule Inhibitors Disrupting the MTDH-SND1 Protein-Protein InteractionHao Shen, Jiayu Ding, Jiaying Ji, et al.
Journal of Medicinal Chemistry|November 9, 2022
Discovery, Optimization, and Evaluation of Selective CDK4/6 Inhibitors for the Treatment of Breast CancerWeijiao Chen, Minghui Ji, Hao Cheng, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Acta Pharmaceutica Sinica. B|November 8, 2021
Tubeimoside-1 induces TFEB-dependent lysosomal degradation of PD-L1 and promotes antitumor immunity by targeting mTORXiaojia Liu, Mingxiao Yin, Jingwen Dong, et al.
Bioorganic & Medicinal Chemistry Letters|March 17, 2020
Lead discovery, chemical optimization, and biological evaluation studies of novel histone methyltransferase SET7 small-molecule inhibitorsZeng Hou, Wenjian Min, Rukang Zhang, et al.
Kidney International|February 19, 2026
Fibrillin-1 is a novel ligand of the epidermal growth factor receptor promoting mesangial cell activation and glomerulosclerosisMeizhi He, Liuyan Xiao, Zhao Liu, et al.
European Journal of Medicinal Chemistry|December 7, 2021
Discovery of novel and orally bioavailable CDK 4/6 inhibitors with high kinome selectivity, low toxicity and long-acting stability for the treatment of multiple myelomaKai Yuan, Wenbin Kuang, Weijiao Chen, et al.
Journal of Medicinal Chemistry|July 4, 2024
Discovery of Potent and Selective c-Met Degraders for Hepatocellular Carcinoma TreatmentWenjian Min, Huanaoyu Yang, Dawei Wang, et al.
International Journal of Biological Sciences|January 29, 2026
Klotho-derived peptide 1 ameliorates hepatic fibrosis induced by αKlotho deficiency and liver injuryHuishi Tan, Wenshu Huang, Hanying Luo, et al.
Bioorganic & Medicinal Chemistry|February 24, 2020
Computational discovery and biological evaluation of novel inhibitors targeting histone-lysine N-methyltransferase SET7Wenjian Min, Zeng Hou, Fang Zhang, et al.
Journal of Medicinal Chemistry|April 27, 2024
Design, Synthesis, and Biological Evaluation of Novel EGFR PROTACs Targeting C797S MutationYasheng Zhu, Xiuquan Ye, Yuxing Wu, et al.
Journal of Medicinal Chemistry|January 10, 2025
Discovery of Novel Small-Molecule Inhibitors Disrupting the MTDH-SND1 Protein-Protein InteractionHao Shen, Jiayu Ding, Jiaying Ji, et al.
Journal of Medicinal Chemistry|November 9, 2022
Discovery, Optimization, and Evaluation of Selective CDK4/6 Inhibitors for the Treatment of Breast CancerWeijiao Chen, Minghui Ji, Hao Cheng, et al.
Pageof 5